Biochemical pharmacology of diabetes and its complications: frontiers in therapy

Diabetes, an intricate chronic metabolic disorder, remains constituting a substantial global health concern, claiming millions of lives each year with no definitive cure currently available to date. Left untreated, diabetes consequently leads to the development of both microvascular as well as macrovascular complications, which are major contributors to the mortality rates among diabetic individuals. The pathogenesis of these complications involves a range of biochemical pathways, including aberrant metabolic pathways, oxidative stress, advanced glycation end products, the activation of protein kinase C, and the implication of various pro-inflammatory cytokines and adipokines. Strategies such as the design of specific inhibitors and antioxidant therapy have shown promise in managing these biochemical processes. In addition, pharmacological approaches have been explored to address the underlying mechanisms of diabetic complications, particularly the polyol pathway. In parallel, nutritional management has emerged as a key component in restoring metabolic balance and improving outcomes for individuals with diabetes. Dietary and diet interventions play a pivotal role in regulating glycemic levels, ameliorating inflammation, and supporting overall metabolic health in diabetic patients. This comprehensive review aims to shed light on the intricate biochemical basis of diabetic complications and explores the latest advancements in pharmacological and nutritional interventions for the effective control of diabetes and its associated consequences. By integrating cutting-edge research findings and practical strategies, this review seeks to provide valuable insights into the multifaceted approach required to combat the challenges posed by diabetes and enhance the quality of care for affected individuals.